“astrazeneca” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare 08/07/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
AstraZeneca to Pay $1B to Team Up With Daiichi Sankyo Again in Cancer 07/27/20 Europe
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
RDMD Lands $14M to Expand Reach of Rare Disease Research Platform 04/16/20 San Francisco
AstraZeneca Wins First FDA Drug Nod for NF1, a Rare Genetic Disorder 04/10/20 National
Page 1 of 14 next page »